ALS Limited

DB:CP4 Stock Report

Market Cap: €4.4b

ALS Valuation

Is CP4 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CP4 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CP4 (€8.95) is trading above our estimate of fair value (€6.38)

Significantly Below Fair Value: CP4 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CP4?

Key metric: As CP4 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CP4. This is calculated by dividing CP4's market cap by their current revenue.
What is CP4's PS Ratio?
PS Ratio2.7x
SalesAU$2.70b
Market CapAU$7.39b

Price to Sales Ratio vs Peers

How does CP4's PS Ratio compare to its peers?

The above table shows the PS ratio for CP4 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.4x
BDT Bertrandt
0.2x4.0%€182.4m
3D6 Avemio
0.3x6.2%€27.2m
GBF Bilfinger
0.4x4.8%€1.7b
AAD Amadeus FiRe
0.9x3.5%€418.3m
CP4 ALS
2.7x7.3%€7.4b

Price-To-Sales vs Peers: CP4 is expensive based on its Price-To-Sales Ratio (2.7x) compared to the peer average (0.4x).

Price to Sales Ratio vs Industry

How does CP4's PS Ratio compare vs other companies in the European Professional Services Industry?

25 CompaniesPrice / SalesEstimated GrowthMarket Cap
CP4 2.7xIndustry Avg. 0.7xNo. of Companies25PS00.81.62.43.24+
25 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CP4 is expensive based on its Price-To-Sales Ratio (2.7x) compared to the European Professional Services industry average (0.7x).

Price to Sales Ratio vs Fair Ratio

What is CP4's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CP4 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.7x
Fair PS Ratio1.1x

Price-To-Sales vs Fair Ratio: CP4 is expensive based on its Price-To-Sales Ratio (2.7x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CP4 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€8.95
€9.60
+7.3%
14.8%€10.92€6.29n/a11
Dec ’25€9.45
€9.57
+1.2%
15.3%€11.00€6.34n/a10
Nov ’25€8.35
€8.80
+5.4%
13.0%€10.31€6.22n/a10
Oct ’25€8.75
€8.80
+0.6%
13.0%€10.31€6.22n/a10
Sep ’25€9.45
€8.92
-5.6%
15.7%€10.48€5.48n/a10
Aug ’25€9.35
€8.68
-7.2%
15.3%€10.25€5.49n/a10
Jul ’25€8.55
€8.61
+0.6%
13.9%€9.55€5.57n/a10
Jun ’25€8.55
€8.61
+0.6%
13.9%€9.55€5.57n/a10
May ’25€7.85
€7.78
-0.9%
11.0%€8.42€5.39n/a10
Apr ’25€7.80
€7.75
-0.6%
11.1%€8.40€5.38n/a10
Mar ’25€7.10
€7.63
+7.5%
11.3%€8.26€5.18n/a10
Feb ’25€7.30
€7.75
+6.2%
11.3%€8.38€5.26n/a10
Jan ’25€7.80
€7.54
-3.3%
11.5%€8.18€5.14n/a10
Dec ’24€7.30
€7.54
+3.3%
11.5%€8.18€5.14€9.4510
Nov ’24€6.25
€7.50
+20.0%
11.9%€8.49€5.06€8.3510
Oct ’24€6.90
€7.50
+8.7%
11.9%€8.49€5.06€8.7510
Sep ’24€6.85
€7.26
+6.0%
11.5%€8.39€5.00€9.4511
Aug ’24€7.15
€7.48
+4.6%
11.7%€8.62€5.13€9.3511
Jul ’24€6.65
€7.48
+12.5%
12.2%€8.63€5.10€8.5511
Jun ’24€6.85
€7.48
+9.2%
12.2%€8.63€5.10€8.5511
May ’24€7.60
€7.87
+3.5%
12.6%€9.00€5.18€7.8511
Apr ’24€7.35
€7.76
+5.5%
12.5%€8.87€5.18€7.8010
Mar ’24€8.10
€8.12
+0.2%
16.3%€9.32€4.60€7.109
Feb ’24€8.25
€8.12
-1.6%
16.3%€9.32€4.60€7.309
Jan ’24€7.60
€8.05
+5.9%
16.1%€9.30€4.59€7.809
Dec ’23€7.75
€8.05
+3.9%
16.1%€9.30€4.59€7.309

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 05:30
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ALS Limited is covered by 28 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Swapan PandyaAPP Securities Pty Ltd.
Russell WrightBarclay Pearce Capital Pty Limited
Megan Kirby-LewisBarrenjoey Markets Pty Limited